Skip to main content
EUDA
NASDAQ Life Sciences

EUDA Health Inks Tri-Party MOU to Develop Next-Gen iPSC and NK-TCR Cell Therapies

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$19
Mkt Cap
$47.392M
52W Low
$5.26
52W High
$86
52W Position info
261% above low
Off High info
78% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

EUDA has more than doubled off its 52-week low of $5.26 on light trading volume (0.1× avg).

Summary

EUDA Health signed a non-binding MOU with GO POSB Organoids and Shenzhen Inno to co-develop, manufacture, and commercialize off-the-shelf oncology cell therapies derived from iPSCs. The collaboration targets cancer treatment and wellness applications, marking a strategic push into next-generation cell therapies. This follows EUDA's recent Nasdaq compliance regain and product launches, signaling an aggressive pivot toward high-value biotech assets. The MOU is early-stage and non-binding, but it opens a new therapeutic vertical for a company with a $47M market cap. Execution risk is high given EUDA's limited in-house R&D and recent dilutive financing history, but the announcement could attract speculative interest in the stock.

At the time of this announcement, EUDA was trading at $19.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $47.4M. The 52-week trading range was $5.26 to $86.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

EUDA - Latest Insights

EUDA
Oct 13, 2026, 10:40 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $16.63
Real-time Price: $14.15 info
Change: -$2.48 (-15%) info
Market Cap: $42.37M info
EUDA
Sep 29, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.90
Real-time Price: $14.15 info
Change: -$1.75 (-11%) info
Market Cap: $42.37M info
EUDA
Jul 28, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $19.90
Real-time Price: $14.15 info
Change: -$5.75 (-29%) info
Market Cap: $42.37M info
EUDA
Jun 10, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $15.46
Real-time Price: $14.15 info
Change: -$1.31 (-8%) info
Market Cap: $42.37M info
EUDA
Jun 01, 2026, 8:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $18.06
Real-time Price: $14.15 info
Change: -$3.91 (-22%) info
Market Cap: $42.37M info